| # | Acquired | Date | Type | Status | Price | |
|---|---|---|---|---|---|---|
| 1 |
Merus
Merus discovers and develops new treatments for cancer using the Multiclonics Pl…
|
2025-09-29 | Acquisition | Pending | $8.0B | Deal → |
| 2 |
ProfoundBio
ProfoundBio is a developer of targeted therapeutics intended for patients with c…
|
2024-04-03 | Acquisition | Complete | $1.8B | Deal → |